Drug Policy Reform Grants for Small Business (SBA-defined)
As of October 2026, Grantoria lists 32 Drug Policy Reform Grants for Small Business (SBA-defined) — 14 open right now, across 7 funding agencies. Award amounts range $10K to $5M. The next application deadline is November 10, 2026. All listings are free, with direct links to the official application.
The National Institutes of Neurological Disorders and Stroke (NINDS) is interested in supporting research projects proposing the optimization and translational development of genomic and biologic therapeutic…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Nov 10, 2026
The purpose of the NIDA Animal Genetics Program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1. Phenotypes associated with addictive behaviors and/or…
🏛 National Institutes of Health📋 CFDA 93.279⏰ Feb 11, 2027
The NIH Blueprint for Neuroscience Research is interested in continuing to support the BluePrint Neurotherapeutics Network for Small Molecules (BPN-SM)- a program designed to help investigators…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Jun 16, 2027
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent…
🏛 National Institutes of Health📋 CFDA 93.350⏰ Jul 2, 2027
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity…
🏛 National Institutes of Health📋 CFDA 93.121⏰ Aug 18, 2027
This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Oct 20, 2027💰
up to $750,000
Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Oct 20, 2027
Reissue of PAR-20-118. This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally…
🏛 National Institutes of Health📋 CFDA 93.242⏰ Oct 25, 2027
Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and…
🏛 National Institutes of Health📋 CFDA 93.242⏰ Oct 25, 2027
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into…
🏛 National Institutes of Health📋 CFDA 93.838⏰ Dec 23, 2027
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into…
🏛 National Institutes of Health📋 CFDA 93.855⏰ Dec 23, 2027
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable…
🏛 National Institutes of Health📋 CFDA 93.350⏰ Feb 17, 2028
This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used…
🏛 National Institutes of Health📋 CFDA 93.866⏰ May 7, 2028💰
up to $1,000,000
How many drug policy reform grants for small business (sba-defined) are available?
Grantoria currently lists 32 drug policy reform grants for small business (sba-defined), of which 14 are open for applications right now. The database is refreshed daily from official federal sources (Grants.gov and SAM.gov).
When is the next deadline?
The next application deadline is November 10, 2026 — about 21 days away. Deadlines vary by program; open any grant to see its exact closing date and application window.
How much funding is available?
Award sizes range from $10K to $5M, depending on the program and applicant. Each grant shows its specific funding range where the agency has published one.
Is Grantoria free to use?
Yes — Grantoria is completely free. No account or subscription is required to browse drug policy reform grants for small business (sba-defined), view deadlines and eligibility, or reach the official application.
How do I apply?
Open any grant to see its full profile — eligibility, required documents, deadlines and a direct link to the official application on the funding agency's website. You apply through the federal portal; Grantoria simply helps you find the right opportunity.
About Drug Policy Reform Grants for Small Business (SBA-defined)
Drug policy reform grants for small businesses range from $875K to $2.0M in typical awards, with 7,381 active opportunities currently available. The National Institutes of Health leads funding in this niche, supported by the Food and Drug Administration and National Institute of Justice. These grants support businesses developing solutions, research capabilities, or pilot initiatives within the drug policy reform space.
All listed grants use competitive application processes, and notably, none require cost-sharing—removing a significant funding barrier for resource-constrained firms. Most awards fund research, pilot programs, or capacity-building efforts. To refine your search, filter by support type to focus on the funding model that best matches your project stage, whether early-stage pilots or established research initiatives.
